Quick Facts
- Type
- Single
- Category
- Hormonal / Growth Hormone
- Vial Strength
- 10 mg
- Status
- Research
Research Purposes Only
This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.
Download Guide
Save the complete Tesamorelin 10mg research guide as a PDF.
Educational and research use only. Not medical advice.
Reference
Sources used for this guide are listed in our research database .
What Is Tesamorelin 10mg?
Tesamorelin 10mg Vial Overview
Tesamorelin is a synthetic GHRH analog consisting of the full 44-amino acid human GHRH sequence with a trans-3-hexenoic acid modification for enhanced stability. It is FDA-approved for reducing excess abdominal fat (lipodystrophy) in HIV-infected patients. Research shows tesamorelin significantly reduces visceral adipose tissue, improves trunk-to-limb fat ratio, and increases IGF-1 without impairing glucose metabolism.
Tesamorelin 10mg Quick Reference
Tesamorelin 10mg Vial Specifications
- Peptide
- Tesamorelin (10 mg Vial) (NNMT inhibitor)
- Vial Content
- 10 mg total peptide
- Category
- Hormonal / Growth Hormone
- Administration Method
- Subcutaneous injection
- Common Use Case
- Visceral fat reduction and physiologic GH optimization
Tesamorelin 10mg Compared With Other Formats
Details that distinguish this 10 mg format include:
- FDA-approved for lipodystrophy—highest regulatory confidence
- Full-length GHRH analog for most physiologic GH release
- Proven visceral fat reduction in clinical trials
The 10 mg vial delivers the FDA-approved 2 mg/day dose for 5 days, ideal for standard visceral fat reduction protocols.
How Does Tesamorelin Work?
Tesamorelin Mechanism of Action
Tesamorelin is the full 44-amino acid human GHRH with a trans-3-hexenoic acid group for enhanced stability. It provides the most physiologic GH stimulation among available GHRH analogs. FDA-approved for HIV-associated lipodystrophy, it reduces visceral adipose tissue by 15–18% without affecting subcutaneous fat or glucose metabolism.
What Are the Potential Benefits of Tesamorelin?
Tesamorelin Research Findings and Observed Outcomes
Findings and reported areas of study for Tesamorelin (10 mg Vial) include:
- Significant visceral fat reduction
- Physiologic GH release pattern
- Improved trunk-to-limb fat ratio
- No glucose metabolism impairment
These observations are discussed for research and educational reference only and are not medical claims.
What Do You Need to Reconstitute Tesamorelin 10mg?
Tesamorelin 10mg Supplies for Reconstitution and Handling
- •Insulin syringes (29–31 gauge)
- •Bacteriostatic water
- •Alcohol prep pads
- •Sharps container
Supplies listed are for laboratory handling and research preparation purposes only.
Tesamorelin 10mg Administration and Research Protocol
Tesamorelin Injection Route, Frequency and Timing
Abdominal injection is standard. Rotate sites.
Tesamorelin 10mg Dosage Guide
Tesamorelin Dosage Ranges
The ranges below pair the listed dose with the draw volume for this product strength.
Tesamorelin 10mg Dosage to Syringe Units
Based on reconstitution below
| Target Daily Dose | Draw Volume | Units |
|---|---|---|
| 1 mg | 0.50 mL | 50 units |
| 2 mg | 1.00 mL | 100 units |
This dosing table is unique to the 10 mg vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).
How Long Does a Tesamorelin 10mg Vial Last?
Tesamorelin 10mg Duration by Research Dose
At common research doses, one 10 mg vial of Tesamorelin typically supports:
Clinical protocols ran 26–52 weeks continuously.
How to Reconstitute Tesamorelin 10mg
Tesamorelin 10mg Reconstitution With Bacteriostatic Water
This section applies specifically to the Tesamorelin (10 mg Vial).
- Recommended Diluent
- Bacteriostatic water
- Diluent Volume
- 5 mL
- Final Concentration
- 2 mg/mL
Tesamorelin 10mg Mixing Instructions
- 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
- 2Wash hands thoroughly and prepare a clean workspace with all supplies.
- 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
- 4Clean the rubber stopper of the vial with an alcohol prep pad.
- 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
- 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
- 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.
Tesamorelin Stacks and Research Combinations
Tesamorelin and Compatible Research Pairings
In research settings, Tesamorelin (10 mg Vial) is sometimes paired with peptides such as:
- Ipamorelin: Premium GH optimization combination
Factors That May Affect Tesamorelin Research Outcomes
Supporting Factors for Tesamorelin Research
Factors recorded alongside this protocol include:
- Balanced nutrition
- Regular exercise targeting visceral fat
- Quality sleep
- Stress management
These factors can affect how research observations are interpreted.
Tesamorelin Side Effects and Safety Considerations
Tesamorelin 10mg Tolerability Notes
FDA-approved with well-characterized safety profile.
Some individuals report:
- Injection site reactions
- Joint pain
- Peripheral edema
- Paresthesia
How to Store Tesamorelin Before and After Reconstitution
Tesamorelin 10mg Storage Requirements
- Unreconstituted
- Refrigerate or freeze
- Reconstituted
- Refrigerate at 2–8°C
- Post-Mix Stability
- Up to 4 weeks
Who Should Avoid Tesamorelin?
This peptide is generally not recommended for:
- Pregnant or breastfeeding individuals
- Active cancer
- Pituitary surgery or disease
- Anyone advised otherwise by a healthcare professional
Tesamorelin 10mg FAQs
Is Tesamorelin FDA-approved?
Yes, under the brand name Egrifta® for reducing excess abdominal fat in HIV-infected patients with lipodystrophy.
Where to Buy Tesamorelin 10mg for Research
Tesamorelin 10mg Purchasing and Research Supply Notes
Before ordering Tesamorelin (10 mg Vial), review the product label, available testing documents, and storage instructions.
Check the ResearchLabs listing for:
- Available testing documents
- Product strength and concentration
- Storage and handling instructions
- Current product availability
View the current listing for Tesamorelin (10 mg Vial):
→ View on ResearchLabsConfirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.
Quick Facts
- Type
- Single
- Category
- Hormonal / Growth Hormone
- Vial Strength
- 10 mg
- Status
- Research
Research Purposes Only
This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.
Download Guide
Save the complete Tesamorelin 10mg research guide as a PDF.
Educational and research use only. Not medical advice.
Reference
Sources used for this guide are listed in our research database .
